This topic contains a solution. Click here to go to the answer

Author Question: A patient is taking gabapentin (Neurontin) for spasticity associated with multiple sclerosis. Which ... (Read 116 times)

ec501234

  • Hero Member
  • *****
  • Posts: 573
A patient is taking gabapentin (Neurontin) for spasticity associated with multiple sclerosis. Which of the following should be the priority for monitoring?
 
  A) Hepatic function
  B) Cardiac function
  C) Respiratory function
  D) Renal function

Question 2

A nurse is assessing a patient who has come to the emergency department complaining of back spasms.
 
  The patient states that he has a history of opioid addiction and does not want to take any drug that puts me at risk of becoming physically dependent. Which of the following medications would the nurse question, if ordered?
  A) Methocarbamol (Robaxin)
  B) Orphenadrine (Norflex)
  C) Cyclobenzaprine (Flexeril)
  D) Metaxalone (Skelaxin)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

adammoses97

  • Sr. Member
  • ****
  • Posts: 337
Answer to Question 1

D

Answer to Question 2

C




ec501234

  • Member
  • Posts: 573
Reply 2 on: Jul 23, 2018
Wow, this really help


JaynaD87

  • Member
  • Posts: 368
Reply 3 on: Yesterday
Gracias!

 

Did you know?

Fewer than 10% of babies are born on their exact due dates, 50% are born within 1 week of the due date, and 90% are born within 2 weeks of the date.

Did you know?

In 1886, William Bates reported on the discovery of a substance produced by the adrenal gland that turned out to be epinephrine (adrenaline). In 1904, this drug was first artificially synthesized by Friedrich Stolz.

Did you know?

Cytomegalovirus affects nearly the same amount of newborns every year as Down syndrome.

Did you know?

Between 1999 and 2012, American adults with high total cholesterol decreased from 18.3% to 12.9%

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library